Coronavirus (COVID-19)Health

Pfizer Ready to Submit Vaccine Data for Youth Soon

US Eases Some International Travel Restrictions

Many parents across the US are celebrating the announcement that their young children may soon be eligible to receive the COVID-19 vaccine. Here is the latest in the fight against the dangerous virus.

Pfizer Makes Important Vaccine Announcement

Pfizer announced on Monday that the latest Phase 2/3 trial demonstrated that its COVID-19 vaccine was safe and effective for children in the age group ranging from 5 to 11. The announcement marks the first time that official results have been results for this age group for a US vaccine. According to Pfizer, they will submit the data to the US Food and Drug Administration (FDA) for emergency use authorization (EUA) shortly. From there, it would likely only take a few weeks for the FDA to recommend the vaccine for widespread use.

Details of Trial

Read More »

Related Articles

Back to top button


Get a daily email of trending news and updates. Be the first to see top stories and events.